jcm-logo

Journal Browser

Journal Browser

Haemodialysis and Peritoneal Dialysis: Current Clinical Practices and Innovations

A Special Issue of Journal of Clinical Medicine (ISSN 2077-0383) belonging to the section "Nephrology & Urology".

Deadline for manuscript submissions: 16 October 2026 | Viewed by 1074

Editor


E-Mail
Guest Editor
Department of Nephrology, Klinikum Rechts der Isar, TUM University Hospital, TUM School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany
Interests: haemodialysis; peritoneal dialysis; chronic kidney disease

Special Issue Information

Dear Colleagues,

End-stage kidney disease (ESKD) represents a growing global health and healthcare challenge, with the demand for renal replacement therapy expected to more than double by 2030. Hemodialysis remains the most commonly used dialysis modality. Thus, enhancing the safety and effectiveness of dialysis has long been a key objective in clinical research.

Unfortunately, many past efforts have failed to clearly demonstrate benefits in terms of patient-relevant outcomes. As a result, there is an urgent need for patient-centered approaches that not only improve survival but also promote patients’ physical and mental wellbeing.

Research in clinical care in dialysis must focus on the following areas:

  • Overcoming sequelae such as chronic uremia and post-dialysis fatigue;
  • Reducing the high costs associated with dialysis care;
  • Minimizing the ecological footprint of dialysis treatment.

The future of dialysis will rely increasingly on the following:

  • The reinforcement of peritoneal dialysis and other home dialysis procedures;
  • The integration of innovative technologies.

We look forward to receiving your submissions.

Dr. Susanne Angermann
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • haemodialysis
  • peritoneal dialysis
  • end-stage kidney disease
  • chronic kidney disease
  • nephrology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 240 KB  
Article
Lower Hospitalization Rates During Fluid Management with Relative Blood Volume Monitoring: A Retrospective Cohort Analysis
by Linda H. Ficociello, Meijiao Zhou, Mianli Xiao, Hao Han, Michael S. Anger, Jeffrey L. Hymes and Dinesh Chatoth
J. Clin. Med. 2026, 15(15), 5821; https://doi.org/10.3390/jcm15155821 - 25 Jul 2026
Viewed by 487
Abstract
Background: Effective fluid management is critical for improving outcomes in patients undergoing chronic hemodialysis (HD). Relative blood volume monitoring (RBVM) supports the optimization of ultrafiltration rate adjustments; however, real-world evidence evaluating its impact on hospitalizations in chronic HD is limited. Methods: We conducted [...] Read more.
Background: Effective fluid management is critical for improving outcomes in patients undergoing chronic hemodialysis (HD). Relative blood volume monitoring (RBVM) supports the optimization of ultrafiltration rate adjustments; however, real-world evidence evaluating its impact on hospitalizations in chronic HD is limited. Methods: We conducted a retrospective, propensity score–matched observational cohort study comparing patient outcomes across 165 Fresenius Kidney Care clinics with high RBVM utilization (HI-RBVM; >90% of treatments) matched to 165 clinics not using RBVM (NO-RBVM). Data were collected from July to December 2022. Primary outcomes were patient-level all-cause and fluid-related hospitalizations and hospitalization days over a 6-month follow-up. Multivariable scaled Poisson regression models were used to estimate adjusted incidence rates, rate ratios, and rate differences. Secondary outcomes included patient-level changes in monthly clinical measurements. Results: 24,958 patients were included (11,840 across HI-RBVM clinics; 13,118 across NO-RBVM clinics). Adjusted incidence rates were lower in the HI-RBVM group compared to the NO-RBVM group for all-cause hospitalizations (1.57 vs. 1.70 per person-year [ppy]), fluid-related hospitalizations (0.30 vs. 0.35 ppy), and hospitalization days (9.60 vs. 10.8 ppy), corresponding to 119 fewer hospital days per 100 patient-years (95% CI: –184, −54; p < 0.001). Among patients with dialysis vintage ≤6 months, those treated in HI-RBVM clinics had smaller increases in pre-HD weight (–0.03 kg vs. +0.46 kg; p = 0.008) and ultrafiltration volume (0.11 L vs. 0.21 L; p = 0.004), and underwent more frequent estimated dry weight (EDW) adjustments (mean 7.73 vs. 6.61; p < 0.001). Conclusions: Among HD patients, high RBVM utilization at the clinic level was associated with lower rates of hospitalization. Prospective or quasi-experimental studies are needed to determine causality. Full article
Back to TopTop